Global Orphan Drug Market 2014 - 2020
- December, 2014
- Domain: Healthcare - Pharmaceuticals
Pages:
Tables:
Charts:
Regions/Countries:
Companies:
Enquiry Hours:
- Get Free 10% Customization in this Report
North America is expected to consume the highest market share because of the growing focus of large pharma sector on the development of orphan drugs. North America is followed by Europe, whose growth is mainly driven by an increase in funding assistance by government for R&D of orphan drugs. The growth in the APAC region growth is driven by an increase in the population of chronic diseases. The major players in the market include Novartis AG, GlaxoSmithKline plc, Merck & Co. Inc., and others.
Infoholic Research’s Global Orphan Drug market report provides detailed information about various market trends and applications covering different segments and regions. The major trends, drivers, restraints and opportunities in each segment are also covered. This study will help stakeholders to understand the current and future market outlook to focus/expand/invest in the Global Orphan Drug market.
This report also provides the competitive landscape of the leading players in Global Orphan Drug market and this study will help the vendors to understand about their competitor’s landscape. The report can also be tailored as per the specific user requirement. The customization of the report is available based on countries, vendor profiles, enterprise, and vertical wise.
1.1 Industry Overview
1.2 Industry Trends
1.3 Pest Analysis
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Total Addressable Market (TAM)
3.2 Segmented Addressable Market (SAM)
3.3 Related Markets
4 Market Outlook
4.1 Overview
4.2 Market Definition – Infoholic Research
4.3 Evolution
4.4 Market Trends
4.5 Importance of Orphan Drugs
4.6 Market Segmentation
4.7 Porter 5(Five) Forces
5 Market Characteristics
5.1 Orphan Drugs Features
5.2 Orphan Drugs Advantages
5.3 Orphan Drugs Scope
5.4 Market Dynamics
5.4.1 Drivers
5.4.2 Opportunities
5.4.3 Restraints
5.4.4 DRO – Impact Analysis
5.4.5 Key Stakeholders
6 Types: Market Size and Analysis
6.1 Overview
6.2 Oncologic diseases
6.3 Metabolic diseases
6.4 Hematologic diseases
6.5 Neurologic diseases
7 Disease Indication: Market Size and Analysis
7.1 Overview
7.2 Acute myeloid leukemia
7.3 Cystic fibrosis
7.4 Glioma
7.5 Ovarian cancer
8 Regions: Market Size and Analysis
8.1 Overview
8.2 Americas
8.3 EMEA
8.4 APAC
9 Market Attractiveness
9.1 Market Attractiveness by Types
9.2 Market Attractiveness by Application
9.3 Market Attractiveness by Disease Indication
9.4 Market Attractiveness by Regions
10 Competitive Landscape
10.1 Overview
10.2 Vendor Assessment
11 Vendor Profiles
12 Companies to Watch For
13 Global Generalist
Annexure
Abbreviations
Research Framework
Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
- Forecasting
Market related information is congregated from both primary and secondary sources.
Primary sources
involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Secondary sources
include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.
